SCI Abstract

search
+
A rare case of giant paraganglioma in the first porta hepatis area associated with neurofibromatosis type 1
A rare case of giant paraganglioma in the first porta hepatis area associated with neurofibromatosis type 1
A rare case of giant paraganglioma in the first porta hepatis area associated with neurofibromatosis type 1
Evolution of two-stage hepatectomy: 25 years of modifications and lessons learned
Evolution of two-stage hepatectomy: 25 years of modifications and lessons learned
Evolution of two-stage hepatectomy: 25 years of modifications and lessons learned
How does obesity develop—and are specific foods to blame?
How does obesity develop—and are specific foods to blame?
How does obesity develop—and are specific foods to blame?
Dapagliflozin for metabolic dysfunction-associated steatohepatitis with fibrosis: a promising therapeutic agent in biopsy-diagnosed patients
Dapagliflozin for metabolic dysfunction-associated steatohepatitis with fibrosis: a promising therapeutic agent in biopsy-diagnosed patients
Dapagliflozin for metabolic dysfunction-associated steatohepatitis with fibrosis: a promising therapeutic agent in biopsy-...
Pancreatobiliary maljunction accompanied by synchronous carcinomas
Pancreatobiliary maljunction accompanied by synchronous carcinomas
Pancreatobiliary maljunction accompanied by synchronous carcinomas
Phenotypic personalized tacrolimus dosing: a step toward precision immunosuppression in liver transplantation
Phenotypic personalized tacrolimus dosing: a step toward precision immunosuppression in liver transplantation
Phenotypic personalized tacrolimus dosing: a step toward precision immunosuppression in liver transplantation
The role of resection margin status on recurrence and selection of patients for adjuvant radiotherapy in distal cholangiocarcinoma
The role of resection margin status on recurrence and selection of patients for adjuvant radiotherapy in distal cholangiocarcinoma
The role of resection margin status on recurrence and selection of patients for adjuvant radiotherapy in distal cholangioc...
Hybrid hepatic artery debranching for pancreatic cancer with celiac axis occlusion
Hybrid hepatic artery debranching for pancreatic cancer with celiac axis occlusion
Hybrid hepatic artery debranching for pancreatic cancer with celiac axis occlusion
Perioperative antibiotic prophylaxis in pancreatoduodenectomy: toward a new standard, but questions remain
Perioperative antibiotic prophylaxis in pancreatoduodenectomy: toward a new standard, but questions remain
Perioperative antibiotic prophylaxis in pancreatoduodenectomy: toward a new standard, but questions remain
Balancing safety and outcomes in minimally invasive liver resection: insights from the PRESSURE trial
Balancing safety and outcomes in minimally invasive liver resection: insights from the PRESSURE trial
Balancing safety and outcomes in minimally invasive liver resection: insights from the PRESSURE trial
Robotic-assisted hepatopancreatoduodenectomy for intraductal papillary neoplasm of the bile duct: future approach for minimally invasive biliary surgery
Robotic-assisted hepatopancreatoduodenectomy for intraductal papillary neoplasm of the bile duct: future approach for minimally invasive biliary surgery
Robotic-assisted hepatopancreatoduodenectomy for intraductal papillary neoplasm of the bile duct: future approach for mini...
Metabolic syndrome and cholangiocarcinoma: large numbers, small risks, but big implications
Metabolic syndrome and cholangiocarcinoma: large numbers, small risks, but big implications
Metabolic syndrome and cholangiocarcinoma: large numbers, small risks, but big implications
Erratum: De-escalating local therapies without compromising outcomes: lessons from the COLLISION trial
Erratum: De-escalating local therapies without compromising outcomes: lessons from the COLLISION trial
Erratum: De-escalating local therapies without compromising outcomes: lessons from the COLLISION trial
The ESSENCE of hope: what semaglutide’s Food and Drug Administration approval means for metabolic dysfunction-associated steatohepatitis
The ESSENCE of hope: what semaglutide’s Food and Drug Administration approval means for metabolic dysfunction-associated steatohepatitis
The ESSENCE of hope: what semaglutide’s Food and Drug Administration approval means for metabolic dysfunction-associated s...
Fabricating transplantable, vascularized, and cholangiogenic bioartificial livers via three-dimensional bioprinting: a promising therapeutic strategy for liver failure
Fabricating transplantable, vascularized, and cholangiogenic bioartificial livers via three-dimensional bioprinting: a promising therapeutic strategy for liver failure
Fabricating transplantable, vascularized, and cholangiogenic bioartificial livers via three-dimensional bioprinting: a pro...
Engineering the tumor microenvironment via 3D multicellular bioprinting for personalized immunotherapy assessment and resistance deciphering
Engineering the tumor microenvironment via 3D multicellular bioprinting for personalized immunotherapy assessment and resistance deciphering
Engineering the tumor microenvironment via 3D multicellular bioprinting for personalized immunotherapy assessment and resi...
Treat-to-target in pancreatic exocrine insufficiency: moving from symptom control to nutrition outcomes
Treat-to-target in pancreatic exocrine insufficiency: moving from symptom control to nutrition outcomes
Treat-to-target in pancreatic exocrine insufficiency: moving from symptom control to nutrition outcomes
Advancing the enhanced recovery after surgery paradigm in liver transplantation: evidence-based strategies for a comprehensive care continuum
Advancing the enhanced recovery after surgery paradigm in liver transplantation: evidence-based strategies for a comprehensive care continuum
Advancing the enhanced recovery after surgery paradigm in liver transplantation: evidence-based strategies for a comprehen...
Remote robot-assisted pancreatoduodenectomy for one patient with pancreatic ductal adenocarcinoma
Remote robot-assisted pancreatoduodenectomy for one patient with pancreatic ductal adenocarcinoma
Remote robot-assisted pancreatoduodenectomy for one patient with pancreatic ductal adenocarcinoma
Pancreatic adenosquamous carcinoma mimicking autoimmune pancreatitis
Pancreatic adenosquamous carcinoma mimicking autoimmune pancreatitis
Pancreatic adenosquamous carcinoma mimicking autoimmune pancreatitis
How to improve the care of decompensated cirrhosis: the intervention model for chronic disease management
How to improve the care of decompensated cirrhosis: the intervention model for chronic disease management
How to improve the care of decompensated cirrhosis: the intervention model for chronic disease management
Tumor burden score and borderline resectability criteria as predictors of survival in advanced hepatocellular carcinoma
Tumor burden score and borderline resectability criteria as predictors of survival in advanced hepatocellular carcinoma
Tumor burden score and borderline resectability criteria as predictors of survival in advanced hepatocellular carcinoma
Advancing surgical techniques: a first application of remote robotic pancreaticoduodenectomy for resectable malignant tumor
Advancing surgical techniques: a first application of remote robotic pancreaticoduodenectomy for resectable malignant tumor
Advancing surgical techniques: a first application of remote robotic pancreaticoduodenectomy for resectable malignant tumor
Balancing efficacy and tolerability in metastatic pancreatic cancer: lessons from the ALPACA trial
Balancing efficacy and tolerability in metastatic pancreatic cancer: lessons from the ALPACA trial
Balancing efficacy and tolerability in metastatic pancreatic cancer: lessons from the ALPACA trial
Updates on the impact of the new liver allocation policy on national liver transplants
Updates on the impact of the new liver allocation policy on national liver transplants
Updates on the impact of the new liver allocation policy on national liver transplants
Neuroendocrine liver metastasis
Neuroendocrine liver metastasis
Neuroendocrine liver metastasis
Call a spade a spade
Call a spade a spade
Call a spade a spade
The value of tranexamic acid in liver resection should not be exaggerated or ignored
The value of tranexamic acid in liver resection should not be exaggerated or ignored
The value of tranexamic acid in liver resection should not be exaggerated or ignored
Empagliflozin for non-diabetic metabolic dysfunction-associated steatotic liver disease: a promising therapeutic agent in transition
Empagliflozin for non-diabetic metabolic dysfunction-associated steatotic liver disease: a promising therapeutic agent in transition
Empagliflozin for non-diabetic metabolic dysfunction-associated steatotic liver disease: a promising therapeutic agent in ...
Implications of the surgical approach for complex liver resection in the era of enhanced recovery programs: a critical appraisal of the “Orange Segments” randomized controlled trial
Implications of the surgical approach for complex liver resection in the era of enhanced recovery programs: a critical appraisal of the “Orange Segments” randomized controlled trial
Implications of the surgical approach for complex liver resection in the era of enhanced recovery programs: a critical app...
Load More
format_indent_increase